15th EGA Conference

The 15th EGA Conference saw the launch of a report from the EGA Health Economics Committee - “How to increase patient access to Generic Medicines in European Healthcare Systems” View report here

In his opening remarks, Mr. Greg Perry, EGA Director General reiterated that generics provide “Headroom for Competition”
  • Sustainablity of pharmaceutical healthcare requires sustainability of a strong competitive and financially healthy EU generic industry.
  • The EU off-patent market must be based on the principle of “headroom for competition”.
  • Ensure that no regulatory, patent or market hurdles exist to the immediate entry of generic medicines on patent expiry
  • Introduce mechanisms to stimulate competition from generic medicines
  • Create a price & reimbursement system for long term competition, not short term savings

Follow the European Commissions’ inquiry and report here Press ReleaseĀ 8th July 2009

0 responses so far. Leave a Comment

Please leave these two fields as-is:

heartReaching out to you

EGA 3rd Bioequivalence Symposium- London, 01st June 2010
DIA 4th Annual Conference in Japan for Asian New Drug Development- Tokyo, 13-14th April 2010
Population Approach Group in Australia & New Zealand (PAGANZ 2010)- Adelaide, 8-10th February 2010
BioPharma Asia Convention- Singapore, 16-18th March 2010
BIO International Convention- Chicago, 3-5th May

Quick contact

place

Suite 126, Kompleks
Eureka, Universiti Sains Malaysia 11800 Penang, Malaysia
Tel: +604-658-9220
Fx: +604-658-4877
Email: admin@info-kinetics.com

About company

Info Kinetics is set up primarily to serve pharmaceutical companies in planning and conducting pharmacokinetic and clinical trials as well as to provide independent analytical services as part of their drug development program.

Copyright © 2010 Info Kinetics Sdn. Bhd. (561937-U) | Terms of Use | Privacy Policy